NAGE
Niagen Bioscience, Inc.
2.80$
+4.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.7% | +4.5% | +2.6% | +12.5% | +13.9% | +4.7% | +2.1% | +9.2% | -0.4% | -7.0% | -5.4% | – | |
| – | +9.7% | +5.3% | +4.0% | +3.3% | +17.0% | +2.0% | -2.3% | +10.7% | +0.6% | -5.2% | -8.9% | – | |
| – | +8.1% | +4.0% | +1.8% | +18.6% | +12.1% | +6.2% | +4.6% | +8.4% | -1.0% | -8.0% | -3.3% | – | |
| – | -6.6% | +80.8% | -37.2% | -2.0% | +1.9% | -4.3% | +24.6% | +14.6% | -4.7% | -13.4% | +2.2% | – | |
| – | -7.1% | -1.4% | +5.8% | +11.3% | -83.3% | +391.4% | +40.2% | -1.9% | +4.9% | -3.1% | -3.8% | – | |
| – | -0.1% | +8.3% | -1.7% | +4.9% | -24.3% | +31.3% | +17.0% | +3.8% | +10.8% | -6.1% | +1.2% | – | |
| – | – | – | – | – | +343.9% | -32.9% | -33.3% | +33.0% | -50.4% | -25.1% | -55.6% | – | |
| – | – | -531.6% | – | – | +298.5% | -30.1% | -28.6% | +28.4% | -7.8% | +52.2% | -84.1% | – | |
| – | – | – | – | – | – | -44.9% | -23.8% | +73.4% | +31.5% | +42.8% | -74.6% | – | |
| – | – | -531.6% | – | – | +282.3% | -29.5% | -28.7% | +26.8% | -9.7% | +52.9% | -84.8% | – | |
| – | – | -120.9% | – | +532.1% | +249.5% | -28.6% | -26.9% | +22.1% | +5.9% | +32.9% | -83.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.